| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |